Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Khiron Life Sciences Corp V.KHRN.H

Alternate Symbol(s):  KHRNF | KHRWF | V.KHRN.WT.H

Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line, the Company is focused on product sales in Latin America. The Company operates its own network of health centers (operating under the Zerenia brand) and Zerenia satellite clinics offering a suite of health, medical and surgical services, in alignment with both insurance company partners and private practice. Its subsidiaries include Khiron Life Sciences Corp. (Canada), Khiron Colombia S.A.S., Zerenia S.A.S., NettaGrowth International Inc., and others.


TSXV:KHRN.H - Post by User

Post by CGCFANon Apr 26, 2021 3:04pm
291 Views
Post# 33068154

$KHRN FINANCIALS / MEXICO

$KHRN FINANCIALS / MEXICO

Hey All 

sent an email to investor relations regarding financials and was told "a date will be released shortly" but nothing definitive was given.
 

similar to everyone else I am extremely interested in this release to see what's been happening and if covid has had any substantial impact on the company. I am also interested to see how perscriptions are going and the sheer volume and increase in the number of them.

Mr Torres continues to be very confident in the YOY growth and states revenues continually increasing.

in the latest Mexico news it was stated they hope to extend until the fall. We will see what happens.

altho yes a nice catalyst , I don't think that's the only one that will send us North.

if the market doesn't like the next release , then I believe we stay in this range for awhile.

It's a shame we couldn't hang on to the .70+ Range as we saw it twice in the last 2 months.

will be on standby for the Mexico news and also the release date for upcoming financials 

its no secret that KHrN has carved a nice little niche market for themselves and as MJ becomes more globally accepted / legal , KHRN will have a great footprint / headstart in LATAM 

GLTA 

<< Previous
Bullboard Posts
Next >>